Asthma is a disease that affects the lungs and is characterized by
wheezing, coughing, breathlessness, and chest tightness. It is a chronic
ailment of the respiratory tract, which is caused by the obstruction of the
flow of air and bronchospasms, where the muscles around the respiratory tract
swell up. The disease is believed to be caused by genetic as well as
environmental factors. The American Academy of Allergy Asthma and Immunology
classifies asthma under four categories: exercise-induced asthma, allergic
asthma, occupational asthma, and childhood asthma. The Asthma and Allergy
Foundation of America classifies asthma into two categories: allergic asthma
and non-allergic asthma. It is an incurable disease but can be controlled with
the help of diagnosis at the right time, followed by regular therapy.
Analysts forecast the Global Asthma Market to grow at a CAGR of 4.50 percent over the period 2013-2018.
Covered in this
Report
This report covers the present scenario and the growth prospects of the
Global Asthma market for the period 2014-2018. To calculate the market size,
the report considers the revenue generated from the sales of various class of
drugs used in the treatment of asthma:
·
• Bronchodilators
·
• Leukotriene antagonists
·
• Mast cell stabilizers
·
• Immunosuppressants
Global Asthma Market 2014-2018, has been prepared based on an in-depth
market analysis with inputs from industry experts. The report covers the
Americas, and the APAC and EMEA regions; it also covers the Global Asthma
Market landscape and its growth prospects in the coming years. The report
includes a discussion of the key vendors operating in this market.
Single User License of the Report is Available
at USD 2500, Buy the Report @ http://www.sandlerresearch.org/purchase?rname=22929 .
